Biomedical Engineering Reference
In-Depth Information
14. Dickinson BL, Badizadegan K, Wu Z, Ahouse JC, Zhu X,
Simister NE, et al. (1999) Bidirectional FcRn-dependent IgG
transport in a polarized human intestinal epithelial cell line. J.
Clin. Invest. 104, 903-911.
15. Haymann J-P, Levraud J-P, Bouet S, Kappes V, Hagege J,
Nguyen G, et al. (2000) Characterization and localization of
the neonatal Fc receptor in adult human kidney. J. Am. Soc.
Nephrol. 11, 632-639.
16. Israel EJ, Taylor S, Wu Z, Mizoguchi E, Blumberg RS,
Bhan A, et al. (1997) Expression of the neonatal Fc recep-
tor, FcRn, on human intestinal epithelial cells. Immunology
92, 69-74.
17. Simister NE, Story CM, Chen H-L, Hunt JS. (1996) An IgG-
transporting Fc receptor expressed in the syncytiotrophoblast
of human placenta. Eur. J. Immunol. 26, 1527-1531.
18. Spiekermann GM, Finn PW, Ward ES, Dumont J, Dickinson
BL, Blumberg RS, et al. (2002) Receptor-mediated immuno-
globulin G transport across mucosal barriers in adult life. J.
Exp. Med. 196, 303-310.
19. Kim J-K, Tsen M-F, Ghetie V, Ward ES. (1994) Localization
of the site of the murine IgG1 molecule that is involved in
binding to the murine intestinal Fc receptor. Eur. J. Immunol.
24, 2429-2434.
20. Ashkenazi A, Capon D, Ward R. (1993) Immunoadhesins.
Int. Rev. Immunol. 10, 219-227.
21. Chamow SM, Ashkenazi A. (1996) Immunoadhesins: princi-
ples and applications. Trends Biotechnol. 14, 52-60.
22. Martin MG, Wu SV, Walsh JH. (1997) Ontogenic develop-
ment and distribution of antibody transport and Fc receptor
mRNA expression in rat
29. Ober RJ, Martinez C, Vaccaro C, Zhou J, Ward ES. (2004)
Visualizing the site and dynamics of IgG salvage by the
MHC class I-related receptor, FcRn. J. Immunol. 172,
2021-2029.
30. Ward ES, Ober RJ, Frederick WA. (2009) Chapter 4. Multi-
tasking by exploitation of intracellular transport functions:
the many faces of FcRn. In: Advances in Immunology.
Academic Press, pp. 77-115.
31. Bitonti AJ, Dumont JA. (2006) Pulmonary administration of
therapeutic proteins using an immunoglobulin transport path-
way. Adv. Drug Deliv. Rev. 58, 1106-1118.
32. Dumont JA, Low SC, Peters RT, Bitonti AJ. (2006) Mono-
meric Fc fusions: impact on pharmacokinetic and biological
activity of protein therapeutics. Biodrugs 20, 151-160.
33. Low SC, Nunes SL, Bitonti AJ, Dumont JA. (2005) Oral
and pulmonary delivery of FSH-Fc fusion proteins via neo-
natal Fc receptor-mediated transcytosis. Hum. Reprod. 20,
1805-1813.
34. Graber SE, Krantz SB. (1978) Erythropoietin and the control
of red cell production. Annu. Rev. Med. 29, 51-66.
35. Dumont JA, Bitonti AJ, Clark D, Evans S, Pickford M,
Newman SP. (2005) Delivery of an erythropoietin-Fc fusion
protein by inhalation in humans through an immunoglobulin
transport pathway. J. Aerosol Med. 18, 294-303.
36. Farquhar MG. (1978) Recovery of surface membrane in
anterior pituitary cells. Variations in traffic detected with
anionic and cationic ferritin. J. Cell Biol. 77, 35-42.
37. Williams MC. (1984) Endocytosis in alveolar type II cells:
effect of charge and size of tracers. Proc. Natl. Acad. Sci. USA
19, 6054-6058.
38. Noseworthy JH, Lucchinetti C, Rodriguez M, Weinshenker
BG. (2000) Multiple sclerosis. N. Engl. J. Med. 343, 938-952.
39. Rubinstein S, Familletti PC, Pestka S. (1981) Convenient
assay for interferons. J. Virol. 37, 755-758.
40. Salmon P, Le Cotonnec J, Galazka A, Abdul-Ahad A,
Darragh A. (1996) Pharmacokinetics and pharmacodynamics
of recombinant human interferon-beta in healthy male
volunteers. J. Interferon Cytokine Res. 16, 759-764.
41. Dumont JA, Low SC, Peters RT, Bitonti AJ. (2009)
Therapeutic Proteins from Bench to Clinic, Chapter 33.
John Wiley & Sons, Inc., pp. 779-795.
42. Vallee S, Rakhe S, Reidy T, Walker S, Lu Q, Sakorafas P, et al.
(2012) Pulmonary administration of IFN beta1a-Fc fusion
protein in non-human primates using an immunoglobulin
transport pathway. J.
intestine. Dig. Dis. Sci. 42,
1062-1069.
23. Roberts DM, Guenthert M, Rodewald R. (1990) Isolation and
characterization of the Fc receptor from the fetal yolk sac of
the rat. J. Cell Biol. 111, 1867-1876.
24. Borvak J, Richardson J, Medesan C, Antohe F, Radu C,
Simionescu M, et al. (1998) Functional expression of the
MHC class I-related receptor, FcRn, in endothelial cells of
mice. Int. Immunol. 10, 1289-1298.
25. Montoyo HP, Vaccaro C, Hafner M, Ober RJ, Mueller W,
Ward ES. (2009) Conditional deletion of the MHC class
I-related receptor FcRn reveals the sites of IgG homeostasis
in mice. PNAS USA 106, 2788-2793.
26. Yoshida M, Masuda A, Kuo T, Kobayashi K, Claypool S,
Takagawa T, et al. (2006) IgG transport across mucosal
barriers by neonatal Fc receptor for IgG and mucosal
immunity. Springer Semin. Immunopathol. 28, 397-403.
27. Telleman P, Junghans RP. (2000) The role of the Brambell
receptor (FcRB) in liver: protection of endocytosed immu-
noglobulin G (IgG) from catabolism in hepatocytes
rather than transport of IgG to bile. Immunology 100,
245-251.
28. Antohe F, Radulescu L, Gafencu A, Ghetie V, Simionescu M.
(2001) Expression of functionally active FcRn and the dif-
ferentiated bidirectional transport of IgG in human placental
endothelial cells. Hum. Immunol. 62, 93-105.
Interferon Cytokine Res. 32(4),
178-184.
43. Brassard DL, Grace MJ, Bordens RW. (2002) Interferon alpha
as an immunotherapeutic protein. J. Leukoc. Biol. 71565-
581.
44. Kozlowski A, Milton Harris J. (2001) Improvements in
protein PEGylation: pegylated interferons for treatment of
hepatitis C. J. Control. Release 72, 217-224.
45. Mannucci PM, Tuddenham EGD. (2001) The hemophilias:
from royal genes to gene therapy. N.Engl.J.Med.344,
1773-1779.
Search WWH ::




Custom Search